Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test BCR ABL t(9:22) Philadelphia Chromosome Test By FISH is typically 5-7 business days. However, this can vary depending on the laboratory and specific circumstances.

What are the prerequisites for the test BCR ABL t(9:22) Philadelphia Chromosome Test By FISH

  • Specimen: Peripheral blood or bone marrow
  • Container: Lavender top (EDTA) tube or green top (sodium heparin) tube
  • Specimen Volume: 5-10 mL
  • Collection: Collect specimen aseptically and mix well
  • Storage Instructions: Refrigerate the specimen
  • Test Performed: Monday - Friday

What are the measure values for the test BCR ABL t(9:22) Philadelphia Chromosome Test By FISH

  • Positive: Presence of BCR-ABL fusion gene
  • Negative: Absence of BCR-ABL fusion gene
  • Borderline: Inconclusive result, further testing may be required

What does this test BCR ABL t(9:22) Philadelphia Chromosome Test By FISH identify?

This test identifies the presence of the BCR-ABL fusion gene, which is associated with the Philadelphia chromosome. This fusion gene is a result of a translocation between chromosomes 9 and 22, leading to the formation of an abnormal hybrid gene. The presence of the BCR-ABL fusion gene is commonly found in patients with chronic myeloid leukemia (CML) and some cases of acute lymphoblastic leukemia (ALL). The identification of this fusion gene through FISH (Fluorescence In Situ Hybridization) testing can help in the diagnosis and monitoring of these types of leukemia.

Why is this test BCR ABL t(9:22) Philadelphia Chromosome Test By FISH taken?

The BCR ABL t(9:22) Philadelphia Chromosome Test By FISH is taken to detect the presence of a specific genetic abnormality known as the Philadelphia chromosome. This abnormality is commonly associated with chronic myeloid leukemia (CML) and a subset of acute lymphoblastic leukemia (ALL).

The test uses fluorescence in situ hybridization (FISH) to identify the translocation of genetic material between chromosomes 9 and 22, resulting in the formation of the Philadelphia chromosome. This translocation leads to the fusion of the BCR and ABL genes, creating a hybrid gene that produces a protein with abnormal tyrosine kinase activity.

Identifying the presence of the Philadelphia chromosome is important for diagnosing and monitoring CML and certain cases of ALL. It can help determine the appropriate treatment options and predict the prognosis for the patient.

Popular FAQs on Test

The BCR ABL t(9:22) Philadelphia Chromosome Test By FISH is a genetic test that detects the presence of a specific chromosomal abnormality associated with chronic myeloid leukemia (CML). This abnormality, known as the Philadelphia chromosome, results from a translocation between chromosomes 9 and 22, leading to the formation of a fusion gene called BCR-ABL.
The test is performed to confirm the diagnosis of chronic myeloid leukemia (CML) and to monitor the effectiveness of treatment. It helps in determining the presence of the Philadelphia chromosome, which is a key genetic marker for CML.
The test is performed on a blood or bone marrow sample. Fluorescent in situ hybridization (FISH) technique is used to detect the BCR-ABL fusion gene on chromosomes 9 and 22. The test provides information about the number of cells that carry the Philadelphia chromosome.
No, the test is not painful. It involves collecting a blood or bone marrow sample, which may cause slight discomfort, but the actual FISH testing is done in a laboratory and does not cause any pain to the patient.
The results of the test are usually available within a few days to a week, depending on the laboratory's turnaround time. The healthcare provider will communicate the results to the patient and discuss the implications of the findings.

Customer Google Rating